28 related articles for article (PubMed ID: 38446902)
1. Subretinal fibrosis secondary to neovascular age-related macular degeneration: mechanisms and potential therapeutic targets.
Zhang J; Sheng X; Ding Q; Wang Y; Zhao J; Zhang J
Neural Regen Res; 2025 Feb; 20(2):378-393. PubMed ID: 38819041
[TBL] [Abstract][Full Text] [Related]
2. Blockade of endothelial adenosine receptor 2 A suppresses atherosclerosis in vivo through inhibiting CREB-ALK5-mediated endothelial to mesenchymal transition.
Cai Y; Zhou Y; Yang Q; Xu J; Da Q; Ma Q; Zhao D; Lu T; Kim HW; Fulton D; Jiang X; Weintraub NL; Dong K; Xu S; Hong M; Liu Z; Huo Y
Pharmacol Res; 2024 May; 203():107156. PubMed ID: 38522762
[TBL] [Abstract][Full Text] [Related]
3. Animal model of subretinal fibrosis without active choroidal neovascularization.
Zandi S; Li Y; Jahnke L; Schweri-Olac A; Ishikawa K; Wada I; Nakao S; Zinkernagel MS; Enzmann V
Exp Eye Res; 2023 Apr; 229():109428. PubMed ID: 36803995
[TBL] [Abstract][Full Text] [Related]
4. YAP is critical to inflammation, endothelial-mesenchymal transition and subretinal fibrosis in experimental choroidal neovascularization.
Yang X; Zou R; Dai X; Wu X; Yuan F; Feng Y
Exp Cell Res; 2022 Aug; 417(2):113221. PubMed ID: 35623419
[TBL] [Abstract][Full Text] [Related]
5. Lycopene inhibits endothelial-to-mesenchymal transition of choroidal vascular endothelial cells in laser-induced mouse choroidal neovascularization.
Li L; Cao X; Huang L; Huang X; Gu J; Yu X; Zhu Y; Zhou Y; Song Y; Zhu M
J Cell Mol Med; 2023 May; 27(10):1327-1340. PubMed ID: 37070131
[TBL] [Abstract][Full Text] [Related]
6. Galectin-1 promotes choroidal neovascularization and subretinal fibrosis mediated via epithelial-mesenchymal transition.
Wu D; Kanda A; Liu Y; Kase S; Noda K; Ishida S
FASEB J; 2019 Feb; 33(2):2498-2513. PubMed ID: 30277820
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of adenosine receptor 2A suppresses endothelial-to-mesenchymal transition and inhibits subretinal fibrosis in mice.
Yang Q; Cai Y; Ma Q; Xiong A; Xu P; Zhang Z; Xu J; Zhou Y; Liu Z; Zhao D; Asara J; Li W; Shi H; Caldwell RB; Sodhi A; Huo Y
Sci Transl Med; 2024 Mar; 16(737):eadk3868. PubMed ID: 38446902
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of subretinal fibrosis in age-related macular degeneration.
Ishikawa K; Kannan R; Hinton DR
Exp Eye Res; 2016 Jan; 142():19-25. PubMed ID: 25773985
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathogenesis of subretinal fibrosis in neovascular AMD focusing on epithelial-mesenchymal transformation of retinal pigment epithelium.
Liu D; Zhang C; Zhang J; Xu GT; Zhang J
Neurobiol Dis; 2023 Sep; 185():106250. PubMed ID: 37536385
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy for Choroidal Neovascularization Due to Uncommon Causes.
Ho CPS; Lai TYY
Curr Pharm Des; 2018; 24(41):4882-4895. PubMed ID: 30727875
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
